Objective: During thoracotomy, positive end-expiratory pressure is applied to the dependent lung and continuous positive airway pressure (CPAP) inflates the nondependent lung to avoid hypoxemia. These methods do not allow the removal of produced secretions. We hypothesized that high-frequency percussive ventilation (HFPV) can improve both conditions and reduce hospital length of stay in these patients.
R espiratory complications are common in pulmonary surgery and a frequent source of increased morbidity and mortality during the perioperative period (1) . During thoracotomy, the nondependent lung might collapse and severe hypox-emia may occur because of a right-toleft shunt (2) . To avoid arterial oxygen desaturation and to improve carbon dioxide removal, presently either positive end-expiratory pressure is applied to the dependent lung and continuous positive airway pressure (CPAP) or high-frequency ventilation with pure oxygen inflates the nondependent lung (3) (4) (5) (6) . These methods do not allow the removal of secretions produced in the nondependent lung during surgery. The decreased bronchial clearance after thoracic surgery can be expected to increase the risk of lung infection, so facilitation of bronchial clearance should be considered a goal to reduce fever and prolongation of length of stay (7) .
High-frequency percussive ventilation (HFPV) is a ventilatory technique providing convective and diffusive ventilation that can reduce the physiologic right-to-left shunt and improve arterial oxygenation. Previous studies demonstrated the efficacy of HFPV in the treatment of closed head injury (8) , acute respiratory diseases caused by burns and smoke inhalation (9 -11) , newborns with hyaline membrane disease and/or acute respiratory distress syndrome (12) , bronchial repair (13) , and recently, in obesity (14) . Furthermore, some studies demonstrated the efficacy of intrapulmonary percussive ventilation in removing bronchial secretions under diverse conditions (15) (16) (17) (18) (19) . No study evaluated HFPV in patients undergoing elective thoracic surgery.
We hypothesized that HFPV can improve oxygenation and the clearance of bronchial secretions, reducing hospital length of stay in patients undergoing partial pneumectomy. Thus, we planned a randomized controlled trial to compare the effects of HFPV and CPAP in patients during partial pulmonary resection. Gas exchange, hemodynamics, quality of surgical field, length of stay, and postoperative pulmonary complications were recorded.
MATERIALS AND METHODS
Fifty-three consecutive patients were enrolled in this randomized prospective study. It was approved by our Institutional Ethics Committee and informed written consent was obtained. To determine sample size, the results of a pilot study (16 vs. 15 patients) were used. The following parameters were taken into consideration: 1) the need to detect an intraoperative difference of 50 mm Hg in PaO 2 between the means provided by the two treatments and SD of 60 mm Hg; 2) a one-tailed significance level (␣) ϭ 0.05; and; 3) a power (1 Ϫ ␤) ϭ 0.80. The sample size amounted to 18 patients in each group, but we cautiously increased it by 20%, reaching 22 subjects/group, because of the possibility that nonparametric tests could be used.
Patients undergoing elective pulmonary partial resection under thoracotomy in the lateral position were included in the study. The exclusion criteria were as follows: 1) primary or postembolic pulmonary arterial hypertension; 2) immunodepression (white blood cell count Ͻ1000/mm 3 ); 3) severe chest deformity; 4) nonoperable lung cancer diagnosed during surgery; 5) those who underwent unexpected pneumonectomy; and 6) intubation with a single lumen tube (using a blocker tube). To prevent imbalances in group assignment, an adaptive allocation randomization was performed by means of the open source statistical package R (20) .
According to these criteria, 44 patients (9 women and 35 men) aged between 40 and 77 years, ASA class II (24 patients) and ASA class III (20 patients), were studied. History of type II diabetes mellitus, hypertension, smoking, and chronic obstructive pulmonary disease (COPD) were considered as independent preoperative risk variables. The preoperative evaluation included routine blood tests, chest radiography, and respiratory function tests. Twenty patients with COPD, according to the World Health Organization classification (21), were included (Table 1) .
Routine anesthesia was induced with diazepam, hydroxyzine, fentanyl, and propofol and maintained with sevorane, fentanyl, and vecuronium according to the local protocol; appropriate fluid balance was maintained. Intubation was achieved with a left-side doublelumen tube (sizes: Ch.39 -41, Rü sch Bronchopart Carlens, Betschdorf, France). Continuous noninvasive monitoring of electrocardiogram, SpO 2 , EtCO 2 , and invasive arterial blood pressure was performed. After turning the patient to lateral decubitus, the proper location of the double-lumen endobronchial tube was confirmed by fiberoptic bronchoscopy. An S/5 Datex-Ohmeda Anesthesia Delivery Unit (Datex-Ohmeda, Bromma, Sweden) was used to ventilate the patients (continuous mechanical ventilation mode) with a total Vt of 8 mL/kg (predicted body weight) during two-lung ventilation, a FIO 2 ϭ 0.5, a positive end-expiratory pressure of 5 cm H 2 O, and a low flow of fresh gas (Ͻ2 L/min) in a semiclosed circuit system. Just before thoracotomy, the ventilation parameters were modified as follows: the dependent lung was ventilated with a tidal volume of 6 mL/kg (predicted body weight), FIO 2 and positive endexpiratory pressure were maintained, and the nondependent lung was excluded. The respiratory rate was adjusted according to the EtCO 2 during both two-lung ventilation and onelung ventilation (OLV) to maintain CO 2 within normal levels. If a sudden drop in SpO 2 (Յ90%) was observed after the onset of OLV or, in any case, after 20 minutes of OLV, the ventilation of the excluded nondependent lung was started. According to the randomization, it was ventilated with HFPV (VDR4, Percussionaire Corporation, Sandpoint, ID) or with a CPAP (Mallinckrodt Medical, Hazelwood, MO) (5 cm H 2 O and 5 L/minute of pure oxygen [FIO 2 ϭ 1.0] delivered by a bubbling humidifier [TR/200 Flow Meter, Levate, Italy]). The HFPV settings were as follows: FIO 2 ϭ 1.0, percussion rate of 500 cycles/minute, T i ϭ 10.5 seconds, T e ϭ 1.5 seconds, a mean pulsatile pressure of 5 cm H 2 O with pressure oscillating between 2 and 8 cm H 2 O; during expiration, oscillatory flow/pressure was discontinued ( Fig. 1 ). If the SpO 2 did not rise during the next 10 minutes after the application of both devices, a rescue therapy would be started by increasing the FIO 2 of the dependent lung up to 1.0. Lung size resection, total time of surgery and OLV, and trial durations did not differ between the HFPV and CPAP groups ( Table 2) .
Five arterial blood samples were collected and analyzed by a blood gas analyzer (Rapidlab 865, Bayer, Leverkusen, Germany): T1, patient in the lateral position for 15 minutes, before chest wall opening, two-lung ventilation; T2, OLV during 20 minutes or less if SpO 2 Յ90%; T3, OLV with CPAP or HFPV applied to the nondependent lung during 15 minutes; T4, same settings as in T3, just before re-expansion; and T5, 15 minutes after re-expansion of the nondependent lung and returning to two-lung ventilation (continuous mechanical ventilation mode) with an overall 8 mL/kg (predicted body weight) Vt. All patients were extubated at the end of surgery and remained in the recovery room during the first 4 postoperative hours. They were then moved to the ward.
During the first 24 to 48 hours, all patients received oxygen therapy in the semirecumbent position with a Venturi mask (Oxinova, Cophos, Grugliasco, Italy) with a mean FIO 2 of 0.35, which resulted in a SpO 2 Ͼ90%. To minimize pain-related bias (22) , a standardized continuous intravenous analgesia was provided and monitored using a visual analogic scale; if visual analogic scale is Ͼ 4 at rest and in movement, a rescue dose of analgesics was administered.
During the postoperative days, vital signs, routine blood analysis, body temperature (the maximum value of four samples in 24 hours), and the amount of sputum collected in a graduate cylinder during physiotherapy and its COPD  I  4  4  II  4  4  III  2  2  IV  0  0 HFPV, high-frequency percussive ventilation; CPAP, continuous positive airway pressure; LDH, serum lactic dehydrogenase; RV/TLC, residual volume/total lung capacity; FEV 1 , forced expiratory volume in 1 sec; FVC, functional residual capacity; COPD, chronic obstructive pulmonary disease (stage I, FEV 1 /FVC Ͻ70% and FEV 1 Ն 80%; stage II, FEV 1 /FVC Ͻ70% and 50% Յ FEV 1 Յ 80%; stage III, FEV 1 /FVC Ͻ70% and 30% Յ FEV 1 Յ 50%; stage IV, FEV 1 /FVC Ͻ70% and FEV 1 Յ30% or Յ50% with respiratory insufficiency or heart failure).
Active smoker is a person who currently smoked at least one cigarette a day (21) . Arterial hypertension is a systolic systemic arterial pressure Ͼ139 mm Hg and diastolic systemic arterial pressure Ͼ89 mm Hg. Data are expressed as mean Ϯ SD or median (first and third quartiles).
daily production were determined on a daily basis. On the fourth day after surgery, chest radiography and blood and sputum culture tests were conducted, and white blood cell count was recorded (23) .
Once a day during the first 4 days after surgery, physiotherapists performed respiratory maneuvers and assisted cough. If required, they used positive expiratory pressure mask and a flow-volumetric inspiratory exerciser (24) . However, their intervention could be extended for a longer period according to the clinical conditions. Routinely, two chest tube (diameter 32 Fr, standard Argyle-type chest tube) drainages were placed intraoperatively for evacuation of blood or air from the pleural cavity and they were removed when three conditions were met: adequate expansion of the lung confirmed by chest radiography, drainage Ͻ200 mL/day, and absence of airleak (25) .
Pneumonia was diagnosed as presence of pulmonary infiltrate on chest radiographic plus two or more of the following criteria: fever Ն38°C, leukocytosis (12 ϫ 10 9 /L), purulent sputum, or isolation of pathogen in expi-ratory secretion. In accordance with the standard recommendation of the Department of Thoracic Surgery, our patients received 1 g/day levofloxacin, even if specific guideline regarding antibiotic prophylactic therapy for pulmonary surgery is not available (26) .
The patients were considered as dischargeable from the hospital by a surgeon not involved in the study if all the following criteria were satisfied: a) body temperature Յ37°C; b) absence of pulmonary parenchyma alterations or heavy pleural effusion on chest radiography; c) SpO 2 Ͼ90% or comparable with the preoperative values (room air); and d) no respiratory complications.
Excepting the operating room personnel, all others involved in the treatment of the patients were blinded in relation to the ventilation pattern used in each case. The same surgeons and anesthetists were involved in all surgeries. None of them took part in data analysis, which was performed by independent physicians.
Statistical Analysis. Statistical analysis was performed by open source statistical package R (20) . Normal distribution of the data was tested by Kolmogorov-Smirnov test (with Lilliefors' correction). The homogeneity of variances was approached with Fisher's F test. If both conditions were satisfied, parametric tests (Student's t test, paired Student's t test, and analysis of variance, followed, if necessary, by multiple comparisons using Tukey test) were used. If any of the conditions was not satisfied, a nonparametric test (Mann-Whitney) was used instead. Kaplan-Meier analysis and likelihood ratio test were applied to determine difference in length of stay. To evaluate sputum production, chi-square, odds ratio, and log-rank test were calculated. To assess the role of each of the four criteria used for discharge, binomial test was used. In all instances, ␣ ϭ 5%.
RESULTS
Of the initially enrolled 53 patients, 9
were not included in the study because of unexpected pneumonectomy (4 patients), nonoperable lung cancer diagnosed during surgery (2 patients), and intubation with a single-lumen tube (3 patients). All patients included in the study did not develop intraoperative surgical or anesthesiologic complications. Table 3 shows arterial blood gases and circulatory parameters during surgery. Both groups presented similar PaO 2 before surgery (T1), after 20 minutes or less of OLV (T2), after 15 minutes of HFPV or CPAP (T3), and at the end of surgery (T5). However, just before re-expansion (T4), the HFPV patients presented higher PaO 2 than those in the CPAP group (p ϭ 0.020). Fifteen minutes after returning to two-lung ventilation (T5), CPAP group presented a tendency to exhibit a smaller PaO 2 than that measured at the beginning of surgery (T1) (p ϭ 0.057).
PaCO 2 , heart rate, and mean arterial pressure did not change either along time or with treatment. Intraoperative liquid balance was similar in both groups (median [first and third quartiles] CPAP: 52.5 [29.2-61] mL/body mass index; HFPV: 44 [28.7-53] mL/body mass index).
Globally, the daily cumulative sputum production statistically differs between the two treatments (log-rank test, z ϭ 6.7, p Ͻ 0.0001), and HFPV patients cleared 72% of their total amount on the fourth postoperative day, whereas CPAP group reached solely 46%. Additionally, HFPV patients reached 50% of sputum elimination 1 day before the CPAP patients. Furthermore, Mann-Whitney test revealed that there was no difference between the overall sputum production between CPAP and HFPV treatments (296 Atypical resection, excision of a portion of lung parenchyma without following the normal anatomical planes. Data are expressed as median (first and third quartiles). and 336 mL, respectively, p ϭ 0.42). If only non-COPD patients treated with CPAP or HFPV were considered, no difference could be detected between the groups (232 and 137 mL, respectively, p ϭ 0.40). On the other hand, the amount of secretions was higher in patients with COPD treated with HFPV than in those who received CPAP (199 and 64 mL, respectively, p ϭ 0.028). Hence, a two-by-two contingency table considering COPD as risk was used, and the analysis revealed that HFPV increased by 5.28 times the chance of sputum production by patients with COPD ( 2 ϭ 46.66, p Ͻ 0.0001; odds ratio ϭ 5.28).
Body temperature Ն38°C was found in eight CPAP patients (two with postoperative pneumonia) and in only two HFPV subjects.
Median duration of drainage was 1.2 days for anterior thoracic space and 3.4 days for posterior. No postoperative hemothorax or pneumothorax was observed. Neither replacement of chest tube nor reoperation was necessary for pleural space problems.
Postoperative pneumonia was diagnosed in two CPAP patients on the following criteria: presence of pulmonary parenchyma consolidation on chest radiography, body temperature Ն38°C, and purulent sputum. They remained under treatment in the ward after the end of protocol (10 days).
In the HFPV group, the number of dischargeable patients amounted to 11 on the fourth day after surgery (Fig. 2) . The HFPV patient considered as dischargeable on the eighth day had a rib fracture and a more complicated clinical evolution. Sixty-eight percent of these patients were considered dischargeable on the fifth day after surgery. In the CPAP group, how-ever, the first six patients could be discharged on the fifth day (27%), three on the 10th day, and two patients (9.1%) remained in the ward because of postoperative pneumonia. On the other hand, on the eighth postoperative day all HFPV patients had been discharged. After having checked for the constancy in the proportional hazard, we compared the two hazard curves (i.e., the probability of achieving the discharge criteria) vs. the ventilatory method used. The two treatments provided significant differences (likelihood ratio test ϭ 11.5, p ϭ 0.0007): a patient treated with HFPV had a 3.14fold larger chance of being discharged earlier than a CPAP-treated subject, as shown in Figure 3 .
We further assessed the role of each of the four criteria used for discharge. Temperature proved to be of paramount importance in determining discharge. If this criterion were removed, the presumed discharge decision would be taken inappropriately earlier in 20 of 44 patients. In fact, the three remaining criteria together would yield a random discharge decision (binomial test, p ϭ 0.651).
DISCUSSION
This is the first study demonstrating that the use of HFPV in the nondependent lung during pulmonary resection increases oxygenation during one OLV, increases the amount of bronchial secretions, and reduces the hospital length of stay in comparison with CPAP ( Fig. 2) .
Volumetric diffusive respiration, commonly called HFPV, is a rhythmic (sinusoidal) cyclic ventilation with physically servoed flow regulation, which produces controlled endobronchial flow/pressure relationships. Over time, HFPV was found effective in patients with severe gas exchange impairment, when continuous mechanical ventilation was demonstrated to be failing (27) . HFPV mechanical properties have been recently described (28, 29) . Based on the Venturi principle, the low-pressure inspiratory circuit, which is connected to the humidification and nebulisation systems, supports a flow volume delivery that is inversely proportional to the pressure reached at the level of the airways; in other words, when the system approaches the desired pressure level, the fraction of delivered air comes almost exclusively from the high-pressure circuit.
Under the surgical point of view, the lungs ventilated with HFPV were almost static and only a small vibration that did not disturb the surgeon could be observed. Additionally, because this is an open system, it offers a less important resistance to the surgical maneuvers. On the other hand, CPAP produces a very inhomogeneous lung surface, a harder lung, and a higher risk of barotrauma.
During the intraoperative period, we used a FIO 2 of 0.5 during bilateral ventilation and in the dependent lung during OLV, whereas pure oxygen is commonly used in these situations (30, 31) . However, elevated FIO 2 produces alveolar damage and inhibits hypoxic pulmonary vasoconstriction (32) . Possibly because of the convective and diffusive ventilation provided by HFPV (33) , this group presented a significantly higher PaO 2 than the CPAP before chest wall closure ( Table  3 , T4). With the pulsatile frequency (500 cycles/minute) and duration of inspiration (10.5 seconds) used in our study, diffusive ventilation was more prominent than the convective component. HFPV, high-frequency percussive ventilation; CPAP, continuous positive airway pressure; T1, patient in the lateral position for 15 min, before chest wall opening, two-lung ventilation; T2, one-lung ventilation for 20 min or less if SpO 2 Յ90%; T3, one-lung ventilation with CPAP or HFPV applied to the nondependent lung during 15 min; T4, same settings as in T3, just before re-expansion; T5, 15 min after re-expansion of the nondependent lung and returning to two-lung ventilation. a Statistically significant difference between the groups; PaO 2 difference between T1 and T5 in CPAP group: p ϭ 0.057. Data are expressed as mean Ϯ SD or median (first and third quartiles).
This setting also allowed the maintenance of physiologic PaCO 2 (Table 3) , in accordance with a previous report of our group (13) . Furthermore, in other experimental setting, high-frequency ventilation improved the lymphatic pump of the pul-monary system avoiding pulmonary edema formation (34) . After returning to two-lung ventilation (T5), blood gases were maintained in HFPV patients in comparison with T1, whereas PaO 2 tended to drop in CPAP group. In line with our results, recently a similar intraoperative PaO 2 trend has been found during OLV with high-frequency jet ventilation and CPAP (at a mean airway pressure of 10 cm H 2 O in the nondependent lung and a FIO 2 ϭ 1.0 in both lungs) in patients undergoing thoracic surgery to correct aneurysms (35) .
In our study, 4.5% of patients developed pneumonia and this finding is within the range reported in the literature (1.5%-25%) (36 -38) . Additionally, the duration of surgery ( Table 2) was similar in the two groups and to the values reported in the literature pertaining to cases with a low infection rate (37, 39) .
HFPV and CPAP groups eliminated the same overall amount of sputum. However, the HFPV group eliminated 50% of the total amount of sputum on the third day after surgery, whereas CPAP group reached the same amount after 1 day. Possibly, the active humidification provided by the VDR4 ventilator associated with low flow of fresh gas (Ͻ2 L/minute) in a semiclosed circuit system used to ventilate the dependent lung could explain, at least in part, these results. Additionally, the pulsatile flow/ pressure helps the removal of secretions (19) . This characteristic is particularly important in patients with COPD who are more prone to develop postoperative pneumonia (39) because of their baseline condition. Our patients with COPD on the HFPV arm removed three times more secretion than those in the CPAP arm at the end of observation. Additionally, the two subjects who developed pneumonia received CPAP treatment during surgery and were patients with COPD (Classes II and III). Finally, our analysis revealed that the intraoperative use of HFPV increased by 5.28 times the chance of sputum production by patients with COPD, in line with previous reports (19, 40, 41) .
HFPV patients met the criteria of discharge from hospital earlier than those in the other group, in line with data from patients with COPD in respiratory failure (42) . Twenty-one of 22 HFPV patients were dischargeable until the seventh day after surgery; the remaining one had a rib fracture that complicated his evolution. On the other hand, 15 CPAP patients could be dischargeable on the seventh day after surgery (Fig. 3) . Furthermore, overall a HFPV-treated subject presented a 3.14-fold larger chance of being discharged earlier than a patient in the CPAP group. Possibly, the same reasons that led to a more important sputum production under HFPV could have played a role in the earlier discharge from hospital in this group.
Our data also revealed that body temperature represented the pivotal parameter to be considered for discharge under the present circumstances in line with common clinical practice. In fact, fever may result from aggressions to different parts of the body (e.g., surgical incision), and in the six CPAP and two HFPV patients, it was self-limiting and developed within the first 48 hours after surgery, probably as a response of the proinflammatory cytokines to surgical injury (43, 44) . On the other hand, chest radiography, sputum, and oxygen saturation are more closely related to a pulmonary condition.
In our study, the prophylactic use of HFPV decreased the postoperative pneumonia incidence, as previously described in burn patients with inhalation injury. In that study, the results were ascribed to the capability of HFPV to improve clearance secretions (45) .
HFPV with its pulsatile flow/pressure pattern avoids mucostasis by modifying mucus rheology by means of a reduction in sputum viscoelasticity (46, 47) . Analogous intraoperative mucus modification could have occurred in our patients, promoting a favorable effect on postoperative respiratory physiotherapy.
Study Limitation. Our study presents some limitations because of the impossibility to quantify the amount of ingested sputum and, despite the standardized protocol, to the difficulty in obtaining a homogeneous respiratory physiotherapy treatment. Furthermore, we cannot exclude that our results could depend in part on uncontrolled variables such as anthropometric characteristics and clinical heterogeneity between the groups. The clinical message of this study should be addressed bearing in mind all the aforementioned limitations.
